Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Dennis A. Revicki, PhD
JCP
Original Research
Reliability and Validity of the Sheehan Irritability Scale in MDD
August 24, 2016
Irritability may influence the course of MDD. Find out whether the Sheehan Irritability Scale can help researchers better determine treatment response in patients with MDD.
Sajjad A. Khan
,
Dennis A. Revicki
,
Mariam Hassan
, et al
JCP
Consensus Statement
Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement
August 16, 2010
Roger E. Meyer
,
Carl Salzman
,
Eric A. Youngstrom
, et al
JCP
Consensus Statement
Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report
July 13, 2010
Roger E. Meyer
,
Carl Salzman
,
Eric A. Youngstrom
, et al
JCP
Original Research
Divalproex Sodium & Olanzapine for Bipolar
March 15, 2003
Read a study analyzing the health and economic outcomes of divalproex and olanzapine in treating acute mania associated with bipolar disorder.
Dennis A. Revicki
,
L. Clark Paramore
,
Kenneth W. Sommerville
, et al
JCP
Article
Pharmacoeconomic Evaluation of Treatments for Refractory Schizophrenia: Clozapine-Related Studies
January 1, 1999
Dennis A. Revicki
JCP
Original Research
Cost-Effectiveness of Newer Antidepressants
February 15, 1997
Dennis A. Revicki
,
Ruth E. Brown
,
Martin B. Keller
, et al